• Publications
  • Fighting the trade in falsified medical produ...
Publication - published on 17 Mar 2016

Fighting the trade in falsified medical products: building a consensus on the role for the private sector

In their article, Laurien Rook, Researcher, and Danny Edwards, Research Programme Manager, at the Access to Medicine Foundation, highlight the ongoing threat falsified medical products pose to global health, and describe the various actions companies take in addressing this issue.

They explain how the 2016 Access to Medicine Index will newly measure company reporting policies for falsified medicines, in order to better understand the full range of company practices in the area, and to build an idea of what best practice in reporting looks like.

The article was published on the Lancet Global Health blog


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.